Literature DB >> 19782035

Drosophila miR2 primarily targets the m7GpppN cap structure for translational repression.

Agnieszka Zdanowicz1, Rolf Thermann, Joanna Kowalska, Jacek Jemielity, Kent Duncan, Thomas Preiss, Edward Darzynkiewicz, Matthias W Hentze.   

Abstract

Understanding the molecular mechanism(s) of how miRNAs repress mRNA translation is a fundamental challenge in RNA biology. Here we use a validated cell-free system from Drosophila embryos to investigate how miR2 inhibits translation initiation. By screening a library of chemical m7GpppN cap structure analogs, we identified defined modifications of the triphosphate backbone that augment miRNA-mediated inhibition of translation initiation but are "neutral" toward general cap-dependent translation. Interestingly, these caps also augment inhibition by 4E-BP. Kinetic dissection of translational repression and miR2-induced deadenylation shows that both processes proceed largely independently, with establishment of the repressed state involving a slow step. Our data demonstrate a primary role for the m7GpppN cap structure in miRNA-mediated translational inhibition, implicate structural determinants outside the core eIF4E-binding region in this process, and suggest that miRNAs may target cap-dependent translation through a mechanism related to the 4E-BP class of translational regulators.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782035     DOI: 10.1016/j.molcel.2009.09.009

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  46 in total

1.  The decapping activator HPat a novel factor co-purifying with GW182 from Drosophila cells.

Authors:  Elisabeth Jäger; Silke Dorner
Journal:  RNA Biol       Date:  2010-05-14       Impact factor: 4.652

Review 2.  The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC.

Authors:  Marc R Fabian; Nahum Sonenberg
Journal:  Nat Struct Mol Biol       Date:  2012-06-05       Impact factor: 15.369

Review 3.  Spotlight on post-transcriptional control in the circadian system.

Authors:  Dorothee Staiger; Tino Köster
Journal:  Cell Mol Life Sci       Date:  2010-08-30       Impact factor: 9.261

4.  Mechanism of translational regulation by miR-2 from sites in the 5' untranslated region or the open reading frame.

Authors:  Francesca Moretti; Rolf Thermann; Matthias W Hentze
Journal:  RNA       Date:  2010-10-21       Impact factor: 4.942

5.  Smaug assembles an ATP-dependent stable complex repressing nanos mRNA translation at multiple levels.

Authors:  Mandy Jeske; Bodo Moritz; Alexander Anders; Elmar Wahle
Journal:  EMBO J       Date:  2010-11-16       Impact factor: 11.598

Review 6.  Diversifying microRNA sequence and function.

Authors:  Stefan L Ameres; Phillip D Zamore
Journal:  Nat Rev Mol Cell Biol       Date:  2013-06-26       Impact factor: 94.444

7.  Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes.

Authors:  Joanna Kowalska; Anna Wypijewska del Nogal; Zbigniew M Darzynkiewicz; Janina Buck; Corina Nicola; Andreas N Kuhn; Maciej Lukaszewicz; Joanna Zuberek; Malwina Strenkowska; Marcin Ziemniak; Maciej Maciejczyk; Elzbieta Bojarska; Robert E Rhoads; Edward Darzynkiewicz; Ugur Sahin; Jacek Jemielity
Journal:  Nucleic Acids Res       Date:  2014-08-22       Impact factor: 16.971

8.  CCR4-NOT deadenylates mRNA associated with RNA-induced silencing complexes in human cells.

Authors:  Xianghua Piao; Xue Zhang; Ligang Wu; Joel G Belasco
Journal:  Mol Cell Biol       Date:  2010-01-11       Impact factor: 4.272

Review 9.  Gene silencing by microRNAs: contributions of translational repression and mRNA decay.

Authors:  Eric Huntzinger; Elisa Izaurralde
Journal:  Nat Rev Genet       Date:  2011-02       Impact factor: 53.242

10.  mRNA isoform diversity can obscure detection of miRNA-mediated control of translation.

Authors:  Jennifer L Clancy; Grace H Wei; Nicole Echner; David T Humphreys; Traude H Beilharz; Thomas Preiss
Journal:  RNA       Date:  2011-04-05       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.